While future studies in large populations of patients with IPF may reveal the critical biological mechanisms that interact with the gain-of-function MUC5B promoter variant to cause IPF, our Muc5b transgenic mice may prove critically important in identifying the genes and/or environmental exposures that contribute to this complex disease. The gene discussed is MUC5B; the disease is idiopathic pulmonary fibrosis.